Bercide, Samuel .

HRN: 26-72-25  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/04/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
08/04/2026
08/10/2026
IV
4.5gms
Q6h
CAP HR
Pending Pharmacy Acceptance 

 Indication:  Empiric Then Culture-directed    Type of Infection:  Pneumonia    Compliance to guidelines: